BerGenBio ASA Statistics

Total Valuation

BerGenBio ASA has a market cap or net worth of NOK 405.26 million. The enterprise value is 230.41 million.

Market Cap	405.26M
Enterprise Value	230.41M

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

BerGenBio ASA has 39.09 million shares outstanding. The number of shares has increased by 305.85% in one year.

Current Share Class	n/a
Shares Outstanding	39.09M
Shares Change (YoY)	+305.85%
Shares Change (QoQ)	+9.81%
Owned by Insiders (%)	4.84%
Owned by Institutions (%)	7.33%
Float	23.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.66
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.51
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.71

Current Ratio	4.71
Quick Ratio	4.23
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -96.83% and return on invested capital (ROIC) is -64.06%.

Return on Equity (ROE)	-96.83%
Return on Assets (ROA)	-52.67%
Return on Capital (ROIC)	-64.06%
Revenue Per Employee	34,733
Profits Per Employee	-10.15M
Employee Count	16
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.06% in the last 52 weeks. The beta is 1.61, so BerGenBio ASA's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-55.06%
50-Day Moving Average	8.89
200-Day Moving Average	19.47
Relative Strength Index (RSI)	63.32
Average Volume (20 Days)	379,688

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BerGenBio ASA had revenue of NOK 521,000 and -152.29 million in losses. Loss per share was -4.75.

Revenue	521,000
Gross Profit	521,000
Operating Income	-161.26M
Pretax Income	-152.29M
Net Income	-152.29M
EBITDA	-161.04M
EBIT	-161.26M
Loss Per Share	-4.75

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	174.84M
Total Debt	n/a
Net Cash	174.84M
Net Cash Per Share	4.47
Equity (Book Value)	153.38M
Book Value Per Share	3.89
Working Capital	153.27M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-138.99M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-30,951.06%
Pretax Margin	-29,230.13%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BerGenBio ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-305.85%
Shareholder Yield	-305.85%
Earnings Yield	-45.78%
FCF Yield	n/a

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 0.01.

Last Split Date	May 30, 2024
Split Type	Reverse
Split Ratio	0.01

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a